Search research articles
Contact Us
Filters
Showing results (51-60 of 432) with videos related to
Page
of 44
Sort By:
Acta Neuropathologica Communications
|
July 20, 2021
The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei
Alyssa N Coyne, Jeffrey D Rothstein
Acta Neuropathologica Communications
|
March 20, 2021
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Alyssa N Coyne, Jeffrey D Rothstein
Journal of Visualized Experiments : Jove
|
September 27, 2021
Nuclei Isolation and Super-Resolution Structured Illumination Microscopy for Examining Nucleoporin Alterations in Human Neurodegeneration
Alyssa N Coyne, Jeffrey D Rothstein
Nucleus (Austin, Tex.)
|
February 21, 2024
Nuclear pore dysfunction and disease: a complex opportunity
Charlotte M Fare, Jeffrey D Rothstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 28, 2022
The Evolving Landscape of Motor Neuron Disease Therapeutics
Nicholas J Maragakis, Jeffrey D Rothstein
Frontiers in Cellular Neuroscience
|
August 5, 2021
RNA Is a Double-Edged Sword in ALS Pathogenesis
Benjamin L Zaepfel, Jeffrey D Rothstein
Gastrointestinal Endoscopy
|
January 29, 2000
Metaplastic ossification of a benign colonic polyp
R D Rothstein, V A LiVolsi
Clinics in Laboratory Medicine
|
June 1, 1996
Interferon and other therapies for hepatitis B and hepatitis C infections
K D Rothstein, S J Munoz
The Virtual Mentor : VM
|
January 17, 2015
Evaluating simulation as a teaching tool in neurosurgery
Brian D Rothstein, Warren R Selman
Nature Reviews. Neurology
|
April 29, 2022
Nuclear pore complexes - a doorway to neural injury in neurodegeneration
Alyssa N Coyne, Jeffrey D Rothstein
Page
of 44
Search research articles
Search
Showing results (51-60 of 432) with videos related to
Sort By:
Page
of 44
Acta Neuropathologica Communications
|
July 20, 2021
The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei
Alyssa N Coyne, Jeffrey D Rothstein
Acta Neuropathologica Communications
|
March 20, 2021
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Alyssa N Coyne, Jeffrey D Rothstein
Journal of Visualized Experiments : Jove
|
September 27, 2021
Nuclei Isolation and Super-Resolution Structured Illumination Microscopy for Examining Nucleoporin Alterations in Human Neurodegeneration
Alyssa N Coyne, Jeffrey D Rothstein
Nucleus (Austin, Tex.)
|
February 21, 2024
Nuclear pore dysfunction and disease: a complex opportunity
Charlotte M Fare, Jeffrey D Rothstein
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 28, 2022
The Evolving Landscape of Motor Neuron Disease Therapeutics
Nicholas J Maragakis, Jeffrey D Rothstein
Frontiers in Cellular Neuroscience
|
August 5, 2021
RNA Is a Double-Edged Sword in ALS Pathogenesis
Benjamin L Zaepfel, Jeffrey D Rothstein
Gastrointestinal Endoscopy
|
January 29, 2000
Metaplastic ossification of a benign colonic polyp
R D Rothstein, V A LiVolsi
Clinics in Laboratory Medicine
|
June 1, 1996
Interferon and other therapies for hepatitis B and hepatitis C infections
K D Rothstein, S J Munoz
The Virtual Mentor : VM
|
January 17, 2015
Evaluating simulation as a teaching tool in neurosurgery
Brian D Rothstein, Warren R Selman
Nature Reviews. Neurology
|
April 29, 2022
Nuclear pore complexes - a doorway to neural injury in neurodegeneration
Alyssa N Coyne, Jeffrey D Rothstein
Page
of 44